Sales UpdateJust checking in to see if there is any evidence of actual sales.
Anxious waiting again for conference calls, but were any sales actually announced?
Looking back at the recent press releases-it seems we are stuck in a waiting period, where no sales happen.
So odd, when the posters talk about how much cardiologists want the product....
Oh well keep waiting I guess.
“The Company has aggressively marketed its VMS+ products at 12 medical conferences this year and engaged hundreds of clinicians. The Company had set a target of 40-45 systems committed to customers by year end. The company has received 6 purchase orders year to date, including orders from Europe, UK, and United States, has 3 installations being arranged and 5 more purchase orders are expected by end of January.
The Company has completed arrangements with 9 regional distributors in the USA, which taken together cover the entire country (see listing on the company’s website). These US-based distributors plus our UK (CardioLogic) and European distributor (AngioPro) and internal staff forms a team of 33 representatives calling on cardiologists. All these representatives are now fully trained and actively following up with their existing customers, as well as the regional leads which were acquired from medical conferences.
With the assistance of our distributors and our internal sales force, the Company now has a list of over 4,000 cardiologists who have a practice where the VMS+ would improve their ability to assess and monitor their patients In addition, our sales team (direct and distributor) already have a relationship with all these potential customers in US, UK and Europe. Hence, the Company now has a full funnel of leads. Our sales team has been actively scheduling appointments to make them aware of the clinical benefits of the VMS+.
The Company continues to be actively working with General Electric HealthCare Corporation (GEHC) through their Edison Development Program1 to bring our cardiac analysis tools to their existing customer base. GEHC is currently being spun out to become a stand-alone company to allow tailored decisions in line with distinct strategies and industry-specific dynamics to accelerate growth across the continuum of care with focused organic investment and strategic M&A.2 “
https://newsdirect.com/news/ventripoint-diagnostics-provides-a-corporate-update-and-announces-new-investor-relations-initiative-788600247
What really happened?
The story of 2s
EDISON is still waiting -2+ years
Sales are still waiting
Looks like the trading is very thin and likely just amongst longs going back-and-forth between themselves while they tell stories about what will be